The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Knight Therapeutics Inc

TSX: GUD
Delayed quote

$9.16

Today's change0.00 0.00%
Updated February 27 4:00 PM EST. Delayed by at least 15 minutes.
 

Knight Therapeutics Inc

TSX: GUD
Delayed quote

$9.16

Today's change0.00 0.00%
Updated February 27 4:00 PM EST. Delayed by at least 15 minutes.

Knight Therapeutics Inc closed at $9.16.

Over the last five days, shares have gained 2.35% and 32.37% year to date. Shares have underperformed the S&P TSX by 0.00% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS--
Updated February 27 4:00 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue000
Total other revenue------
Total revenue000
Gross profit------
Total cost of revenue------
Total operating expense210
Selling / general / administrative110
Research & development100
Depreciation / amortization000
Interest expense (income), net operating------
Unusual expense (income)------
Other operating expenses, total00--
Operating income-200
Interest income (expense), net non-operating000
Gain (loss) on sale of assets------
Other------
Income before tax100
Income after tax100
Income tax, total000
Net income100
Total adjustments to net income------
Net income before extra. items100
Minority interest------
Equity in affiliates------
U.S. GAAP adjustment------
Inc. avail. to common excl. extra. items100
Inc. avail. to common incl. extra. items100
Diluted net income100
Dilution adjustment----0
Diluted weighted average shares78638
Diluted EPS excluding extraordinary itemsvalue per share0.010.01-0.01
Dividends per sharevalue per share0.000.000.00
Diluted normalized EPSvalue per share0.010.01-0.01